Max Narovlyansky

Max Narovlyansky, PhD, is a scientist and entrepreneur with a focus on the design and use of medical devices, particularly in the realm of microfluidics and point-of-care diagnostics. Currently a Senior Scientist at Xheme, they are working on innovative solutions to reduce oxidative stress in bioprocessing. Max previously founded FlowCell, a marketplace for precision medicine tools, and served in various roles at notable institutions such as Abbott and Merck, specializing in data analysis, regulatory processes, and assay development. With a Bachelor's and PhD from Harvard University, they have cultivated a strong background in biochemistry and clinical testing.